NCT06829472View on ClinicalTrials.gov

Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan

PHASE3RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

July 1, 2026

Study Completion Date

December 1, 2026

Conditions

ToxicitiesSurvivorship

Interventions

DRUG

melphalan

conditioning regimen with melphalan, busulfan and fludarabine

Trial Locations (2)

200025

RECRUITING

Rui Jin Hospital, Shanghai

Unknown

NOT_YET_RECRUITING

Zhaxin Hospital, Go Broad Health Care, Shanghai

All Listed Sponsors

collaborator

Shanghai Clinical Research Center

UNKNOWN

lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT06829472 - Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan | Biotech Hunter | Biotech Hunter